Patient P-03440
Therapy response
Favorable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
33%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S16
- Day 57 HY-01 recommended — Hydration Protocol HY-01
- Day 58 Patient accepted — Started HY-01 in the companion
- Day 62 No meaningful change — Hydration Protocol HY-01
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+19
- Inflammatory activity+6
- Nutritional resilience-6
- Treatment adherence+3
- Toxicity-2
What helped?
- Hydration Protocol HY-01Day 57Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.9/10
stable · +0.2 vs previous 14 d
Stress level
Daily log4.4/10
stable · -0.1 vs previous 14 d
Pessimism score
Daily log3.4/10
improving · -0.1 vs previous 14 d
Sleep quality
Wearable61.7/100
improving · +3.2 vs previous 14 d
Libido
Daily log4.6/10
improving · +0.3 vs previous 14 d
HRV
Wearable46.4 ms
improving · +2.8 vs previous 14 d
Toxicity
Blood14.1/100
improving · -11.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 87 from the failing basin, 4 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.8 next day on high-intake days · n 23
Would not help
- HY-01 Hydration Protocolalready tried, no meaningful change
- Keep alcohol lowGI +3.7 next day on high-intake days · n 19
- Keep lactose lowGI +3.7 next day on high-intake days · n 28
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Alcohol+3.7detractor · 95%
- Lactose+3.7detractor · 95%
- Dietary fat load+1.5no signal · 42%
- Caffeine+1.3no signal · 41%
- Histamine load-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3 · butyrate capacity 54/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 49 ms
- Sleep
- 7.6 h
- Steps
- 7,727
- Resting HR
- 66 bpm
Daily log: GI score 19, nutritional resilience 67, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03008 | 46% | S16 | SC-12 | improved | 87 |
| P-03165 | 46% | S06 | NP-02 | improved | 79 |
| P-03288 | 43% | S15 | CR-01 | improved | 88 |
| P-03140 | 41% | S20 | AD-05 | improved | 79 |
| P-03188 | 41% | S13 | HY-01 | improved | 79 |
| P-03333 | 40% | S14 | SC-12 | improved | 91 |
| P-03431 | 40% | S05 | DT-01 | improved | 88 |
| P-03001 | 39% | S04 | CR-01 | improved | 87 |
| P-03018 | 39% | S05 | ME-01 | improved | 84 |
| P-03449 | 33% | S14 | DT-01 | improved | 79 |
| P-03208 | 32% | S02 | BR-03 | improved | 57 |
| P-03252 | 32% | S13 | SC-12 | improved | 68 |